Cancer Drug Development Problems and Opportunities

Drug information journal : DIJ / Drug Information Association volume 32, pages1–5(1998)Cite this article

Abstract

The pharmaceutical industry must direct additional focus on the development of agents to prevent or minimize symptoms of cancer and its treatment, and maximize the quality of life of cancer patients. This paper covers the current status of cancer chemotherapy, opportunties for intervention, supportive care measures, and challenges to the pharmuceutical industry in oncologic drug development.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Author information

Affiliations

  1. The Cleveland Clinic Cancer Center, and the Department of Hematologyhledical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA, 9500 Euclid Avenue

    Maurie Markman MD

Authors
  1. Maurie Markman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurie Markman MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Markman, M. Cancer Drug Development Problems and Opportunities. Ther Innov Regul Sci 32, 1–5 (1998). https://doi.org/10.1177/009286159803200101

Download citation

Key Words

  • Cancer
  • Oncologic drug development
  • Pharmaceutical industry